Akers Biosciences, Inc. Business Finance Contracts & Agreements
58 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Note Agreements (3)
- Purchase Agreements (11)
- Registration Rights Agreements (2)
- Stock Agreements (7)
- Subscription Agreements (2)
- Underwriting Agreements (4)
- Waiver Agreements (1)
- Warrant Agreements (26)
- Stock Purchase Agreement, dated as of October 1, 2024, by and between TNF Pharmaceuticals, Inc. and Prevail Partners, LLC (Filed With SEC on October 7, 2024)
- Form of Amendment to Series G Short Term Warrant (Filed With SEC on August 19, 2024)
- Form of Amendment to Series G Long Term Warrant (Filed With SEC on August 19, 2024)
- Form of Amendment to Series F-1 Short Term Warrant (Filed With SEC on August 19, 2024)
- Form of Amendment to Series F-1 Long Term Warrant (Filed With SEC on August 19, 2024)
- Form of Omnibus Waiver and Amendment, dated April 5, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Filed With SEC on April 8, 2024)
- Form of Purchase Agreement (Filed With SEC on February 21, 2023)
- Form of Warrant (Filed With SEC on February 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on August 15, 2022)
- Form of Warrant (Filed With SEC on August 15, 2022)
- Form of Placement Agent Warrant Certificate (Filed With SEC on March 31, 2022)
- Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings, LLC and MyMD Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)
- Amended and Restated Confirmatory Patent Assignment and Royalty Agreement dated November 11, 2020, by and between SRQ Patent Holdings II, LLC and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)
- Asset Purchase Agreement, dated November 11, 2020, by and between MyMD Pharmaceuticals, Inc. and Supera Pharmaceuticals, Inc (Filed With SEC on May 18, 2021)
- Form of Restricted Stock Award Agreement (Filed With SEC on April 22, 2021)
- Form of Nonqualified Stock Option Agreement (Filed With SEC on April 22, 2021)
- Form of Placement Agent Warrant (Filed With SEC on November 18, 2020)
- Form of Securities Purchase Agreement, dated November 11, 2020, by and between Akers Biosciences, Inc. and purchasers named therein (Filed With SEC on November 12, 2020)
- The Secured Promissory Note, dated November 11, 2020, by and between Akers Biosciences, Inc. and MYMD Pharmaceuticals, Inc (Filed With SEC on November 12, 2020)
- Form of Investor Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)
- Form of Pre-Funded Warrant. of Akers Biosciences, Inc (Filed With SEC on November 12, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on August 13, 2020)
- Form of Placement Agent Warrant (Filed With SEC on August 13, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)
- Form of Placement Agent Warrant (Filed With SEC on May 15, 2020)
- Amendment No. 1 to the Membership Interest Purchase Agreement, dated May 14, 2020 (Filed With SEC on May 15, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on April 8, 2020)
- Form of Placement Agent Warrant (Filed With SEC on April 8, 2020)
- Registration Rights Agreement (Filed With SEC on March 24, 2020)
- Membership Interest Purchase Agreement (Filed With SEC on March 24, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on November 29, 2019)
- Form of Placement Agent Warrant Certificate (Filed With SEC on November 29, 2019)
- Form of Pre-Funded Warrant Certificate (Filed With SEC on November 29, 2019)
- Form of Series C Convertible Preferred Stock Warrant Certificate (Filed With SEC on November 29, 2019)
- Form of Securities Purchase Agreement, dated October 31, 2018, by and among the Company and the investors signatory thereto (Filed With SEC on October 31, 2018)
- Form of Warrant (Filed With SEC on October 31, 2018)
- Underwriting Agreement, dated December 18, 2017, between Akers Biosciences, Inc. and Joseph Gunnar & Co., LLC as representative of the several underwriters named therein (Filed With SEC on December 19, 2017)
- Form of Underwriters Warrant (Filed With SEC on December 15, 2017)
- Form of Underwriting Agreement (Filed With SEC on December 15, 2017)
- Form of Common Stock Purchase Warrant (Filed With SEC on December 14, 2017)
